InMode Ltd.
NASDAQ:INMDMedical - Devices
+$0.04 today
- Market cap
- $741.17M
- Beta
- 1.93
- P/E (TTM)
- 9.7
- EPS (TTM)
- $1.38
Volume 0.31M
Average 0.85M
INMD Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
InMode Ltd.NASDAQ: INMD
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization growth accelerates
Q1 FY2026 depreciation & amortization of $175K rose 0.6% year over year, ahead of the -5.6% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 0.6% from the prior quarter. Over 3 fiscal years it compounded at +0.7% a year.
Context
- Depreciation & amortization amounted to 0.2% of revenue in FY2025, unchanged from a year earlier.
- Depreciation & amortization increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +0.6% holds above the trailing-twelve-month pace of -5.6%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2025
- 695K USD
- Year-over-year change
- -4.5%
- 4-year CAGR
- +7.7%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 695K | -4.5% |
| FY2024 | 2024-12-31 | 728K | +16.9% |
| FY2023 | 2023-12-31 | 623K | -8.4% |
| FY2022 | 2022-12-31 | 680K | +31.5% |
| FY2021 | 2021-12-31 | 517K | — |
Depreciation & Amortization vs competitors
How INMD compares with its peers on the latest reported figures
- INMD's LTM Mar 2026 depreciation & amortization of $696K is the lowest of the 5 companies compared; the peer median is $18.54M.
- Its year-over-year change of -5.6% is the 3rd highest of 5, against a peer median of -9.1%.
- Depreciation & amortization amounts to 0.2% of revenue for INMD, versus a peer median of 6.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $157.69M | +1.3% | +23.6% | 3.8% | |
| LTM Mar 2026 | $24.52M | -21.4% | +3.5% | 8.3% | |
| LTM Mar 2026 | $12.56M | +1.9% | +16.6% | 8.3% | |
| LTM Sep 2026 | $8.13M | -19.5% | +34.1% | 3.1% | |
| LTM Mar 2026 | $696K | -5.6% | +0.7% | 0.2% | |
| Peer median (excluding INMD) | $18.54M | -9.1% | +20.1% | 6.0% | |
Competitors are the stored peer set for INMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 357.57M | 454.27M | 492.05M | 394.82M | 370.5M |
| Cost of Revenue | 53.59M | 73.49M | 80.71M | 77.75M | 79.53M |
| Gross Profit | 303.97M | 380.79M | 411.34M | 317.07M | 290.97M |
| Gross Margin | 85.0% | 83.8% | 83.6% | 80.3% | 78.5% |
| Research & Development | 9.53M | 12.43M | 13.41M | 13.14M | 13.32M |
| Selling, General & Admin | 127.76M | 170.51M | 202.27M | 191.4M | 192.26M |
| Operating Expenses | 136.5M | 182.93M | 215.68M | 204.54M | 205.58M |
| Depreciation & Amortization | 517K | 680K | 623K | 728K | 695K |
| EBITDA | 168.52M | 202.15M | 217.89M | 144.2M | 111.03M |
| EBITDA Margin | 47.1% | 44.5% | 44.3% | 36.5% | 30.0% |
| Operating Income | 167.48M | 197.85M | 195.66M | 112.53M | 85.39M |
| Operating Margin | 46.8% | 43.6% | 39.8% | 28.5% | 23.0% |
| Interest Income | 525K | 3.61M | 21.61M | 30.94M | 24.94M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 525K | 3.61M | 21.61M | 30.94M | 24.94M |
| Income Before Tax | 168M | 201.47M | 217.27M | 143.47M | 110.33M |
| Pre-Tax Margin | 47.0% | 44.3% | 44.2% | 36.3% | 29.8% |
| Income Tax Expense | 2.93M | 39.95M | 19.35M | (37.81M) | 16.5M |
| Net Income | 164.97M | 161.52M | 197.92M | 181.28M | 93.83M |
| Net Margin | 46.1% | 35.6% | 40.2% | 45.9% | 25.3% |
| EPS (Basic) | 2.03 | 1.96 | 2.37 | 2.29 | 1.45 |
| EPS (Diluted) | 1.92 | 1.89 | 2.30 | 2.25 | 1.43 |
| Weighted Avg Shares | 81.44M | 82.48M | 83.53M | 79.31M | 64.63M |
| Weighted Avg Shares (Diluted) | 86.02M | 85.4M | 85.95M | 80.6M | 65.44M |
InMode Ltd.
NASDAQ:INMD
Intrinsic Alpha fair value
Locked
Current Price
$12.88
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.